Natural antioxidant compounds in risk factors for CVD

Pharmacological Research

Volumn 56, Issue 2, 2007, Pages 99-109

  Kaliora, Andriana C ^a   Dedoussis, George V Z ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Antioxidants; CVD; Human studies; Hyperglycemia; Hyperlipidemias; Hypertension

Indexed keywords

ACHILLEA WILHELMSII EXTRACT; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; FLAVONOID; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN; PHYTOSTEROL; UBIDECARENONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG EFFICACY; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; LIFESTYLE; LOW FAT DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT REFUSAL; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; OXIDATIVE STRESS; RISK FACTORS; TREATMENT OUTCOME;

EID: 34548140158     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.04.018     Document Type: Review

References (104)

1. McInnes G.T. How important is optimal blood pressure control?. Clin Ther 26 (2004) 3-11
2. Barrett-Connor E., and Orchard T.J. Insulin-dependent diabetes mellitus and ischemic heart disease. Diabetes Care 8 (1985) S65-S70
3. Kaliora A.C., Dedoussis G.V.Z., and Schmidt H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 187 (2006) 1-17
4. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
5. Berry C., Hamilton C.A., Brosnan M.J., Magill F.G., Berg G.A., McMurray J.J., et al. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101 (2000) 2206-2212
6. Germano G., Sanguigni V., Pignatelli P., Caccese D., Lenti L., Ragazzo M., et al. Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens 22 (2004) 1151-1156
7. Timimi F.K., Ting H.H., Haley E.A., Roddy M.A., Ganz P., and Creager M.A. Vitamin C improves endothelium dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31 (1998) 552-557
8. Cosentino F., Hishikawa K., Katusic Z.S., and Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96 (1997) 25-28
9. Wolin M.S. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20 (2000) 1430-1442
10. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002) 1656-1662
11. Ohara Y., Peterson T.E., Sayegh H.S., Subramanian R.R., Wilcox J.N., and Harrison D.G. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92 (1995) 898-903
12. Davi G., Alessandrini P., Mezzetti A., Minotti G., Bucciarelli T., Costantini F., et al. In vivo formation of 8-epiprostaglandin F2a is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 17 (1997) 3230-3235
13. Sanguigni V., Pignatelli P., Caccese D., Pulcinelli F.M., Lenti L., Magnaterra R., et al. Increased superoxide anion production by platelets in hypercholesterolemic patients. Thromb Haemost 87 (2002) 796-801
14. Ferro D., Parrotto S., Basili S., Alessandri C., and Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 36 (2000) 427-431
15. Hodis H.N., et al. α-Tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention study (VEAPS). Circulation 106 (2002) 1453-1459
16. Carpenter K.L., Kirkpatrick P.J., Weissberg P.L., Challis I.R., Dennis I.F., Freeman M.A., et al. Oral α-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions. Free Radic Res 37 (2003) 1235-1244
17. Samman S., Sivarajah G., Man J.C., Ahmad Z.I., Petocz P., and Caterson I.D. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 133 (2003) 2188-2193
18. Murphy K.J., Chronopoulos A.K., Singh I., Francis M.A., Moriarty H., Pike M.J., et al. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77 (2003) 1466-1473
19. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
20. Touyz R.M. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1 (2003) 91-106
21. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288 (2002) 2998-3007
22. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336 (1997) 1117-1124
23. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al., DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344 (2001) 3-10
24. Duffy S.J., Gokce N., Holbrook M., Huang A., Frei B., Keaney Jr. J.F., et al. Treatment of hypertension with ascorbic acid. Lancet 354 (1999) 2048-2049
25. Fotherby M.D., Williams J.C., Forster L.A., Craner P., and Ferns G.A. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 18 (2000) 411-415
26. Hajjar I.M., George V., Sasse E.A., and Kochar M.S. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 9 (2002) 289-293
27. Block G. Ascorbic acid, blood pressure, and the American Diet. Ann N Y Acad Sci 959 (2002) 180-187
28. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., et al. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 277 (1997) 1624-1632
29. Ness A.R., Chee D., and Elliott P. Vitamin C and blood pressure: an overview. J Hum Hypertens 11 (1997) 343-350
30. Block G., Mangel A.R., Norkus E.P., Patterson B.H., Levander O.A., and Taylor P.R. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 37 (2001) 261-267
31. Mullan B.A., Young I.S., Fee H., and McCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40 (2002) 804-809
32. Kim M.K., Sasaki S., Okubo S., Hayashi M., and Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 40 (2002) 797-803
33. Palumbo G., Avanzini F., Alli C., Roncaglioni M.C., Ronchi E., Cristofari M., et al. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)-Hypertension study. Am J Hypertens 13 (2000) 564-567
34. Boshtam M., Rafiei M., Sadeghi K., and Sarraf-Zadegan N. Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res 72 (2002) 309-314
35. Teede H.J., Giannopoulos D., Dalais F.S., Hodgson J., and McGrath B.P. Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects. J Am Coll Nutr 25 (2006) 533-540
36. Reshef N., Hayari Y., Goren C., Boaz M., Madar Z., and Knobler H. Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am J Hypertens 18 (2005) 1360-1363
37. Ward N.C., Hodgson J.M., Croft K.D., Burke V., Beilin L.J., and Puddey I.B. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 23 (2005) 427-434
38. Keli S.O., Hertog M.G., Feskens E.J., and Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156 (1996) 637-642
39. Singh R.B., Niaz M.A., Rastogi S.S., Shukla P.K., and Thakur A.S. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Hum Hypertens 13 (1999) 203-208
40. Burke B.E., Neuenschwander R., and Olson R.D. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J 94 (2001) 1112-1117
41. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
42. Saxena A.K., Srivastava P., Kale R.K., and Baquer N.Z. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 45 (1993) 539-542
43. Mayer-Davis E.J., Monaco J.H., Marshall J.A., Rushing J., and Juhaeri J. Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus. From the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study. Prev Med 26 (1997) 277-283
44. Mayer-Davis E.J., Costacou T., King I., Zaccaro D.J., and Bell R.A. The Insulin Resistance and Atherosclerosis Study (IRAS). Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 25 (2002) 2172-2177
45. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328 (1993) 1450-1456
46. McCarty M.F. Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics?. Med Hypotheses 52 (1999) 397-400
47. Niaz M.A., Singh R.B., and Rastogi S.S. Effect of hydrosoluble coenzyme Q10 on the lipoprotein (a) and insulin sensitivity in rabbits receiving trans fatty acid rich diet. J Trace Elem Exp Med 11 (1998) 275-288
48. Ford E.S., Will J.C., Bowman B.A., and Narayan K.M. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149 (1999) 168-176
49. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67 (2005) 3-21
50. Monnier V.M., Mustata G.T., Biemel K.L., Rheil O., Lederer M.O., Yu D.Z., et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Ann N Y Acad Sci 1043 (2005) 533-544
51. Peyroux J., and Sternberga M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathologie Biologie 54 (2006) 405-419
52. Giardino I., Edelstein D., Horiuchi S., Araki N., and Brownlee M. Vitamin E prevents diabetes-induced formation of arterial wall intracellular advanced glycation endproducts. Diabetes 44 (1995) 73A
53. 2+-catalyzed oxidation. Free Radic Res 32 (2000) 439-449
54. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26 (2003) 1589-1596
55. Konen J.C., Summerson J.H., and Kirk J.K. Measurement feasability of advanced glycated end-products from skin samples after antioxidant vitamin supplementation in patients with type 2 diabetes. J Nutr Health Aging 4 (2000) 81-84
56. Shoff S.M., Mares-Perlman J.A., Cruickshanks K.J., Klein R., Klein B.E.K., and Ritter L.L. Glycated hemoglobin concentrations and vitamin E, vitamin C, and beta-carotene intake in diabetic and nondiabetic older adults. Am J Clin Nutr 58 (1993) 412-416
57. Boeing H., Weisgerber U.M., Jeckel A., Rose H.-J., and Kroke A. Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: crosssectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 71 (2000) 1115-1122
58. Sternberg M.C., Borsos A.M., Roux A., Adam C., and Urios P. Compared inhibition of pentosidine formation in type-I collagen incubated with glucose by catechin, myricetin, kaempferol and quercetin: role of flavonoid structure. Diabetologia 45 Suppl 2 (2002) A393-A394
59. Urios P., Kassab I., Borsos A.M., Guillot R., Peyroux J., and Sternberg M. Long-term treatment with a purified micronized flavonoid fraction reduces urinary albumin clearance and restores albuminemia in normotensive and hypertensive diabetic rats. Diabetes Res Clin Pract 50 Suppl 1 (2000) S362
60. Chong P.H., and Bachenheimer B.S. Current, new and future treatments in dyslipidaemia and atherosclerosis. Drugs 60 (2000) 55-93
61. Shidfar F., Keshavarz A., Jallali M., Miri R., and Eshraghian M. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients. Int J Vitam Nutr Res 73 (2003) 163-170
62. O'Byrne D., Grundy S., Packer L., Devaraj S., Baldenius K., Hoppe P.P., et al. Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 29 (2000) 834-845
63. Gupta R., Singhal S., Goyle A., and Sharma V.N. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India 49 (2001) 231-235
64. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107 (2003) 947-953
65. Qureshi A.A., Qureshi N., Wright J.J., Shen Z., Kramer G., Gapor A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvitee). Am J Clin Nutr 53 (1991) 1021-1026
66. Khor H.T., Chieng D.Y., and Ong K.K. Tocotrienols inhibit HMG-CoA reductase activity in the guinea pig. Nutr Res 15 (1995) 537-544
67. Watkins T., Lenz P., Gapor A., Struck M., Tomeo A., and Bierenbaum M. Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28 (1993) 1113-1138
68. Qureshi A.A., Bradlow B.A., Salser W.A., and Brace L.D. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J Nutr Biochem 8 (1997) 290-298
69. Qureshi A.A., Qureshi N., Hasler-Rapacz J.O., Weber F.E., Chaudhary V., Crenshaw T.D., et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apoliprotein B, thromboxan B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 53 (1991) 1042S-1046S
70. Wahlqvist M.L., Krivokuca-Bogetic Z., Lo C.H., Hage B., Smith R., and Lukito W. Differential serum responses to tocopherols and tocotrienols during vitamin E supplementation in hypercholesterolemic individuals without change in coronary risk factors. Nutr Res 12 (1992) 181-201
71. Mensink R.P., Van Houwelingen A.C., Kromhout D., and Honstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 69 (1999) 213-219
72. Qureshi A.A., Sami S.A., Salser W.A., and Khan F.A. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 12 (2001) 318-329
73. Asgary S., Naderi G.H., Sarrafzadegan N., Mohammadifard N., Mostafavi S., and Vakili R. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii. Drugs Exp Clin Res 26 (2000) 89-93
74. Maron D.J., Lu G.P., Cai N.S., Wu Z.G., Li Y.H., Chen H., et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 163 (2003) 1448-1453
75. Wangen K.E., Duncan A.M., Xu X., and Kurzer M.S. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73 (2001) 225-231
76. Howes J.B., Sullivan D., Lai N., Nestel P., Pomeroy S., West L., et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152 (2000) 143-147
77. Dewell A., Hollenbeck C.B., and Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 87 (2002) 118-121
78. Lichtenstein A.H., Jalbert S.M., Adlercreutz H., Goldin B.R., Rasmussen H., Schaefer E.J., et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 22 (2002) 1852-1858
79. Meyer B.J., Larkin T.A., Owen A.J., Astheimer L.B., Tapsell L.C., and Howe P.R. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48 (2004) 67-78
80. Weststrate J.A., and Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52 (1998) 334-343
81. Hallikainen M.A., and Uusitupa M.I. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69 (1999) 403-410
82. Hendriks H.F., Weststrate J.A., van Vliet T., and Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53 (1999) 319-327
83. Nguyen T.T., Dale L.C., von Bergmann K., and Croghan I.T. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin Proc 74 (1999) 1198-1206
84. Sierksma A., Weststrate J.A., and Meijer G.W. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations. Br J Nutr 82 (1999) 273-282
85. Plat J., van Onselen E.N., van Heugten M.M., and Mensink R.P. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 54 (2000) 671-677
86. Hallikainen M.A., Sarkkinen E.S., Gylling H., Erkkila A.T., and Uusitupa M.I. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54 (2000) 715-725
87. Christiansen L.I., Lahteenmaki P.L., Mannelin M.R., Seppanen-Laakso T.E., Hiltunen R.V., and Yliruusi J.K. Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. Eur J Nutr 40 (2001) 66-73
88. Nestel P., Cehun M., Pomeroy S., Abbey M., and Weldon G. Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur J Clin Nutr 55 (2001) 1084-1090
89. Fuhrman B., Elis A., and Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 233 (1997) 658-662
90. Agarwal S., and Rao A.V. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33 (1998) 981-984
91. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., and Mitchinson M.J. Randomised controlled trial of Vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (1996) 781-786
92. Gotto A.M. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 41 (2003) 1205-1210
93. Kritchevsky S.B., Shimakawa T., Tell G.S., Dennis B., Carpenter M., Eckfeldt J.H., et al. Dietary antioxidants and carotid artery wall thickness. The ARIC study. Atherosclerosis Risk in Communities study. Circulation 92 (1995) 2142-2150
94. Nyyssonen K., Parviainen M.T., Salonen R., Tuomilehto J., and Salonen J.T. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 314 (1997) 634-638
95. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet 342 (1993) 1007-1011
96. Street D.A., Comstock G.W., and Salkeld R.M. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction?. Circulation 90 (1994) 1154-1161
97. Kohlmeier L., Kark J.D., Gomez-Gracia E., Martin B.C., Steck S.E., Kardinaal A.F., et al. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146 (1997) 618-626
98. Hak A.E., Stampfer M.J., Campos H., Sesso H.D., Gaziano J.M., Willett W., et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 108 (2003) 802-807
99. Bonithon-Kopp C., Coudray C., Berr C., Touboul P.J., Feve J.M., Favier A., et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 year. The EVA study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 65 (1997) 121-127
100. Gale C.R., Ashurst H.E., Powers H.J., and Martyn C.N. Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr 74 (2001) 402-408
101. Gianetti J., Pedrinelli R., Petrucci R., Lazzerini G., De Caterina M., Bellomo G., et al. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 143 (2002) 467-474
102. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23 (2004) 423-433
103. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 361 (2003) 2017-2023
104. Pryor W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 28 (2000) 141-164